Christopher R Ensor

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Induction immunosuppression for orthotopic heart transplantation: a review
    Christopher R Ensor
    Comprehensive Transplant Center, Johns Hopkins Hospital, 600 North Wolfe St, Carnegie 180, Baltimore, MD 21287, USA
    Prog Transplant 19:333-41; quiz 342. 2009
  2. doi Proliferation signal inhibitor toxicities after thoracic transplantation
    Christopher R Ensor
    University of Maryland School of Pharmacy, The Johns Hopkins Hospital, Comprehensive Transplant Center, Department of Pharmacy Practice and Science, Baltimore MD 21287 6180, USA
    Expert Opin Drug Metab Toxicol 9:63-77. 2013
  3. doi Generic maintenance immunosuppression in solid organ transplant recipients
    Christopher R Ensor
    Comprehensive Transplant Center, The Johns Hopkins Hospital, University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    Pharmacotherapy 31:1111-29. 2011
  4. ncbi Capnocytophagia canimorsus sepsis in an asplenic heart transplant candidate with a left ventricular assist system
    Christopher R Ensor
    Department of Pharmacy, The Johns Hopkins Hospital, Comprehensive Transplant Center, 600 North Wolfe St, Carnegie 180, Baltimore, MD 21287 6180, USA
    Prog Transplant 21:121-3. 2011
  5. doi Pharmacotherapy for mechanical circulatory support: a comprehensive review
    Christopher R Ensor
    School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Ann Pharmacother 45:60-77. 2011
  6. pmc Antithrombotic therapy for the CardioWest temporary total artificial heart
    Christopher R Ensor
    Department of Pharmacy, Comprehensive Transplant Center, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA
    Tex Heart Inst J 37:149-58. 2010
  7. doi Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center
    Martin A Bishop
    From the Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland Division of Hematology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland
    ASAIO J 60:193-8. 2014
  8. doi Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network
    Sherry K Milfred-Laforest
    Department of Pharmacy, Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, USA
    J Card Fail 19:354-69. 2013
  9. doi Development and implementation of a pharmacist-managed inpatient anticoagulation monitoring program
    Jessica C Wellman
    Ambulatory Care and Anticoagulation Management, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Am J Health Syst Pharm 68:934-9. 2011
  10. doi Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients
    Lauren M Hynicka
    School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Ann Pharmacother 46:558-66. 2012

Collaborators

Detail Information

Publications10

  1. ncbi Induction immunosuppression for orthotopic heart transplantation: a review
    Christopher R Ensor
    Comprehensive Transplant Center, Johns Hopkins Hospital, 600 North Wolfe St, Carnegie 180, Baltimore, MD 21287, USA
    Prog Transplant 19:333-41; quiz 342. 2009
    ..To describe the appropriateness and safety of induction immunosuppression for patients at risk for fatal rejection, and to describe the safety and effectiveness profiles of the induction regimens available in the United States...
  2. doi Proliferation signal inhibitor toxicities after thoracic transplantation
    Christopher R Ensor
    University of Maryland School of Pharmacy, The Johns Hopkins Hospital, Comprehensive Transplant Center, Department of Pharmacy Practice and Science, Baltimore MD 21287 6180, USA
    Expert Opin Drug Metab Toxicol 9:63-77. 2013
    ..Additionally, these drugs may result in renal sparing and express potent anti-viral activity. However, they are fraught with substantial and complex toxicities that limit their use...
  3. doi Generic maintenance immunosuppression in solid organ transplant recipients
    Christopher R Ensor
    Comprehensive Transplant Center, The Johns Hopkins Hospital, University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    Pharmacotherapy 31:1111-29. 2011
    ....
  4. ncbi Capnocytophagia canimorsus sepsis in an asplenic heart transplant candidate with a left ventricular assist system
    Christopher R Ensor
    Department of Pharmacy, The Johns Hopkins Hospital, Comprehensive Transplant Center, 600 North Wolfe St, Carnegie 180, Baltimore, MD 21287 6180, USA
    Prog Transplant 21:121-3. 2011
    ..He improved after administration of broad-spectrum antibiotics, which were narrowed to ampicillin/sulbactam for a prolonged 6-week course, and subsequently recovered fully...
  5. doi Pharmacotherapy for mechanical circulatory support: a comprehensive review
    Christopher R Ensor
    School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Ann Pharmacother 45:60-77. 2011
    ....
  6. pmc Antithrombotic therapy for the CardioWest temporary total artificial heart
    Christopher R Ensor
    Department of Pharmacy, Comprehensive Transplant Center, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA
    Tex Heart Inst J 37:149-58. 2010
    ..The development and monitoring of individualized antithrombotic regimens require that informed health professionals appreciate the complexities and grasp the hazards that are associated with these therapies...
  7. doi Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center
    Martin A Bishop
    From the Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland Division of Hematology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland
    ASAIO J 60:193-8. 2014
    ..026). There was no difference in the rate per patient-year of bleeding (0.23 vs. 0.33, p = 0.55) or thrombotic events (0.12 vs. 0.13, p = 0.88). Pharmacist-managed INR PST is associated with an increased %TTR in patients with LVADs. ..
  8. doi Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network
    Sherry K Milfred-Laforest
    Department of Pharmacy, Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, USA
    J Card Fail 19:354-69. 2013
    ..This situation is a "perfect storm" of factors that predispose patients to medication errors...
  9. doi Development and implementation of a pharmacist-managed inpatient anticoagulation monitoring program
    Jessica C Wellman
    Ambulatory Care and Anticoagulation Management, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Am J Health Syst Pharm 68:934-9. 2011
    ..CONCLUSION. Case-based advanced training and implementation of an IAP in a tertiary care hospital increased pharmacists' involvement in the management of inpatients receiving anticoagulants...
  10. doi Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients
    Lauren M Hynicka
    School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Ann Pharmacother 46:558-66. 2012
    ..To review the literature regarding current strategies and strategies under active development for the prevention and treatment of respiratory syncytial virus (RSV) infections in immunocompromised adults...